
Non-invasive glucose monitoring device could measure your glucose without hurt your finger. Non-invasive glucose monitoring device refers to the measurement of blood glucose levels (required by people with diabetes to prevent both chronic and acute complications from the disease) without drawing blood, puncturing the skin, or causing pain or trauma.In this report, we study both disposable sensors and durable systems.
The global market for Non-invasive Glucose Monitoring Device was estimated to be worth US$ 5097.3 million in 2023 and is forecast to a readjusted size of US$ 25860 million by 2030 with a CAGR of 25.8% during the forecast period 2024-2030
Market is really concentrated. Abbott and DexCom accounted for 54.33% and 47.03% market share in 2019.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Non-invasive Glucose Monitoring Device, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Non-invasive Glucose Monitoring Device by region & country, by Type, and by Application.
The Non-invasive Glucose Monitoring Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-invasive Glucose Monitoring Device.
Market Segmentation
By Company
DexCom
Abbott
Cnoga Medical
Integrity Applications
Taiwan Biophotonic
MediWise
GlySens Incorporated
Segment by Type:
Wearable Devices
Non-wearable Devices
Segment by Application
Hospital
Home Care
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Non-invasive Glucose Monitoring Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Non-invasive Glucose Monitoring Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Non-invasive Glucose Monitoring Device in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Non-invasive Glucose Monitoring Device Product Introduction
1.2 Global Non-invasive Glucose Monitoring Device Market Size Forecast
1.2.1 Global Non-invasive Glucose Monitoring Device Sales Value (2019-2030)
1.2.2 Global Non-invasive Glucose Monitoring Device Sales Volume (2019-2030)
1.2.3 Global Non-invasive Glucose Monitoring Device Sales Price (2019-2030)
1.3 Non-invasive Glucose Monitoring Device Market Trends & Drivers
1.3.1 Non-invasive Glucose Monitoring Device Industry Trends
1.3.2 Non-invasive Glucose Monitoring Device Market Drivers & Opportunity
1.3.3 Non-invasive Glucose Monitoring Device Market Challenges
1.3.4 Non-invasive Glucose Monitoring Device Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Non-invasive Glucose Monitoring Device Players Revenue Ranking (2023)
2.2 Global Non-invasive Glucose Monitoring Device Revenue by Company (2019-2024)
2.3 Global Non-invasive Glucose Monitoring Device Players Sales Volume Ranking (2023)
2.4 Global Non-invasive Glucose Monitoring Device Sales Volume by Company Players (2019-2024)
2.5 Global Non-invasive Glucose Monitoring Device Average Price by Company (2019-2024)
2.6 Key Manufacturers Non-invasive Glucose Monitoring Device Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Non-invasive Glucose Monitoring Device Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Non-invasive Glucose Monitoring Device
2.9 Non-invasive Glucose Monitoring Device Market Competitive Analysis
2.9.1 Non-invasive Glucose Monitoring Device Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Non-invasive Glucose Monitoring Device Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Glucose Monitoring Device as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Wearable Devices
3.1.2 Non-wearable Devices
3.2 Global Non-invasive Glucose Monitoring Device Sales Value by Type
3.2.1 Global Non-invasive Glucose Monitoring Device Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Non-invasive Glucose Monitoring Device Sales Value, by Type (2019-2030)
3.2.3 Global Non-invasive Glucose Monitoring Device Sales Value, by Type (%) (2019-2030)
3.3 Global Non-invasive Glucose Monitoring Device Sales Volume by Type
3.3.1 Global Non-invasive Glucose Monitoring Device Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Non-invasive Glucose Monitoring Device Sales Volume, by Type (2019-2030)
3.3.3 Global Non-invasive Glucose Monitoring Device Sales Volume, by Type (%) (2019-2030)
3.4 Global Non-invasive Glucose Monitoring Device Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Home Care
4.1.3 Other
4.2 Global Non-invasive Glucose Monitoring Device Sales Value by Application
4.2.1 Global Non-invasive Glucose Monitoring Device Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Non-invasive Glucose Monitoring Device Sales Value, by Application (2019-2030)
4.2.3 Global Non-invasive Glucose Monitoring Device Sales Value, by Application (%) (2019-2030)
4.3 Global Non-invasive Glucose Monitoring Device Sales Volume by Application
4.3.1 Global Non-invasive Glucose Monitoring Device Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Non-invasive Glucose Monitoring Device Sales Volume, by Application (2019-2030)
4.3.3 Global Non-invasive Glucose Monitoring Device Sales Volume, by Application (%) (2019-2030)
4.4 Global Non-invasive Glucose Monitoring Device Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Non-invasive Glucose Monitoring Device Sales Value by Region
5.1.1 Global Non-invasive Glucose Monitoring Device Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Non-invasive Glucose Monitoring Device Sales Value by Region (2019-2024)
5.1.3 Global Non-invasive Glucose Monitoring Device Sales Value by Region (2025-2030)
5.1.4 Global Non-invasive Glucose Monitoring Device Sales Value by Region (%), (2019-2030)
5.2 Global Non-invasive Glucose Monitoring Device Sales Volume by Region
5.2.1 Global Non-invasive Glucose Monitoring Device Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Non-invasive Glucose Monitoring Device Sales Volume by Region (2019-2024)
5.2.3 Global Non-invasive Glucose Monitoring Device Sales Volume by Region (2025-2030)
5.2.4 Global Non-invasive Glucose Monitoring Device Sales Volume by Region (%), (2019-2030)
5.3 Global Non-invasive Glucose Monitoring Device Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Non-invasive Glucose Monitoring Device Sales Value, 2019-2030
5.4.2 North America Non-invasive Glucose Monitoring Device Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Non-invasive Glucose Monitoring Device Sales Value, 2019-2030
5.5.2 Europe Non-invasive Glucose Monitoring Device Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Non-invasive Glucose Monitoring Device Sales Value, 2019-2030
5.6.2 Asia Pacific Non-invasive Glucose Monitoring Device Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Non-invasive Glucose Monitoring Device Sales Value, 2019-2030
5.7.2 South America Non-invasive Glucose Monitoring Device Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Non-invasive Glucose Monitoring Device Sales Value, 2019-2030
5.8.2 Middle East & Africa Non-invasive Glucose Monitoring Device Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Non-invasive Glucose Monitoring Device Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Non-invasive Glucose Monitoring Device Sales Value
6.2.1 Key Countries/Regions Non-invasive Glucose Monitoring Device Sales Value, 2019-2030
6.2.2 Key Countries/Regions Non-invasive Glucose Monitoring Device Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Non-invasive Glucose Monitoring Device Sales Value, 2019-2030
6.3.2 United States Non-invasive Glucose Monitoring Device Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Non-invasive Glucose Monitoring Device Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Non-invasive Glucose Monitoring Device Sales Value, 2019-2030
6.4.2 Europe Non-invasive Glucose Monitoring Device Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Non-invasive Glucose Monitoring Device Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Non-invasive Glucose Monitoring Device Sales Value, 2019-2030
6.5.2 China Non-invasive Glucose Monitoring Device Sales Value by Type (%), 2023 VS 2030
6.5.3 China Non-invasive Glucose Monitoring Device Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Non-invasive Glucose Monitoring Device Sales Value, 2019-2030
6.6.2 Japan Non-invasive Glucose Monitoring Device Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Non-invasive Glucose Monitoring Device Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Non-invasive Glucose Monitoring Device Sales Value, 2019-2030
6.7.2 South Korea Non-invasive Glucose Monitoring Device Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Non-invasive Glucose Monitoring Device Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Non-invasive Glucose Monitoring Device Sales Value, 2019-2030
6.8.2 Southeast Asia Non-invasive Glucose Monitoring Device Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Non-invasive Glucose Monitoring Device Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Non-invasive Glucose Monitoring Device Sales Value, 2019-2030
6.9.2 India Non-invasive Glucose Monitoring Device Sales Value by Type (%), 2023 VS 2030
6.9.3 India Non-invasive Glucose Monitoring Device Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 DexCom
7.1.1 DexCom Company Information
7.1.2 DexCom Introduction and Business Overview
7.1.3 DexCom Non-invasive Glucose Monitoring Device Sales, Revenue and Gross Margin (2019-2024)
7.1.4 DexCom Non-invasive Glucose Monitoring Device Product Offerings
7.1.5 DexCom Recent Development
7.2 Abbott
7.2.1 Abbott Company Information
7.2.2 Abbott Introduction and Business Overview
7.2.3 Abbott Non-invasive Glucose Monitoring Device Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Abbott Non-invasive Glucose Monitoring Device Product Offerings
7.2.5 Abbott Recent Development
7.3 Cnoga Medical
7.3.1 Cnoga Medical Company Information
7.3.2 Cnoga Medical Introduction and Business Overview
7.3.3 Cnoga Medical Non-invasive Glucose Monitoring Device Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Cnoga Medical Non-invasive Glucose Monitoring Device Product Offerings
7.3.5 Cnoga Medical Recent Development
7.4 Integrity Applications
7.4.1 Integrity Applications Company Information
7.4.2 Integrity Applications Introduction and Business Overview
7.4.3 Integrity Applications Non-invasive Glucose Monitoring Device Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Integrity Applications Non-invasive Glucose Monitoring Device Product Offerings
7.4.5 Integrity Applications Recent Development
7.5 Taiwan Biophotonic
7.5.1 Taiwan Biophotonic Company Information
7.5.2 Taiwan Biophotonic Introduction and Business Overview
7.5.3 Taiwan Biophotonic Non-invasive Glucose Monitoring Device Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Taiwan Biophotonic Non-invasive Glucose Monitoring Device Product Offerings
7.5.5 Taiwan Biophotonic Recent Development
7.6 MediWise
7.6.1 MediWise Company Information
7.6.2 MediWise Introduction and Business Overview
7.6.3 MediWise Non-invasive Glucose Monitoring Device Sales, Revenue and Gross Margin (2019-2024)
7.6.4 MediWise Non-invasive Glucose Monitoring Device Product Offerings
7.6.5 MediWise Recent Development
7.7 GlySens Incorporated
7.7.1 GlySens Incorporated Company Information
7.7.2 GlySens Incorporated Introduction and Business Overview
7.7.3 GlySens Incorporated Non-invasive Glucose Monitoring Device Sales, Revenue and Gross Margin (2019-2024)
7.7.4 GlySens Incorporated Non-invasive Glucose Monitoring Device Product Offerings
7.7.5 GlySens Incorporated Recent Development
8 Industry Chain Analysis
8.1 Non-invasive Glucose Monitoring Device Industrial Chain
8.2 Non-invasive Glucose Monitoring Device Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Non-invasive Glucose Monitoring Device Sales Model
8.5.2 Sales Channel
8.5.3 Non-invasive Glucose Monitoring Device Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
DexCom
Abbott
Cnoga Medical
Integrity Applications
Taiwan Biophotonic
MediWise
GlySens Incorporated
Ìý
Ìý
*If Applicable.
